Data gathered: January 2
AI Stock Analysis - Bioventus (BVS)
Analysis generated January 1, 2025. Powered by Chat GPT.
Bioventus is a medical technology company that focuses on developing innovations for healing and regeneration. With a broad array of products, the company aims to enhance the quality of life for patients who need musculoskeletal or wound healing therapies. The company has a clear vision focused on advancing healthcare around the globe.
Stock Alerts - Bioventus (BVS)
 |
Bioventus | December 27 Price is down by -5.5% in the last 24h. |
|
Bioventus | December 27 Insider Alert: Singleton Mark Leonard is selling shares |
|
Bioventus | December 11 AI Score is up by 22.5% in the last couple of days. |
|
Bioventus | December 5 Price is up by 5.3% in the last 24h. |
Alternative Data for Bioventus
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 40 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| Patents | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 627 | Sign up | Sign up | Sign up |
| Instagram Followers | 656 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 420 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,867 | Sign up | Sign up | Sign up |
| Twitter Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 24,700 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 83 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,141 | Sign up | Sign up | Sign up |
About Bioventus
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.
| Price | $10.50 |
| Target Price | Sign up |
| Volume | 567,560 |
| Market Cap | $686M |
| Year Range | $3.96 - $13.71 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Medical Devices |
In the news
 |
Mark Leonard Singleton Sells 10,733 Shares of Bioventus Inc. (NYSE:BVS) StockDecember 28 - ETF Daily News |
|
Bioventus Inc. (NYSE:BVS) SVP Katrina J. Church Sells 2,535 Shares of StockDecember 27 - ETF Daily News |
 |
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?December 22 - Yahoo |
Bioventus Inc.(NasdaqGS: BVS) added to S&P Healthcare Equipment Select Industry IndexDecember 22 - Finnhub |
|
 |
Bioventus (NYSE:BVS) Upgraded at JPMorgan Chase & Co.December 19 - ETF Daily News |
|
EP Wealth Advisors LLC Acquires New Stake in Bioventus Inc. (NYSE:BVS)December 16 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 139M | 131M | 94M | -4.8M | 6.1M | 0.060 |
| Q2 '24 | 151M | 176M | 104M | -24M | -27M | 0.190 |
| Q1 '24 | 129M | 121M | 88M | -4.6M | -1.7M | 0.070 |
| Q4 '23 | 135M | 130M | 86M | -6.1M | -4.5M | 0.070 |
| Q3 '23 | 118M | 114M | 79M | -7.3M | -4.2M | 0.050 |
Insider Transactions View All
| D'Adamio Anthony filed to sell 109,578 shares at $10.5. December 26 '24 |
| CHURCH KATRINA J filed to sell 47,264 shares at $10.5. December 26 '24 |
| Singleton Mark Leonard filed to sell 105,162 shares at $10.5. December 26 '24 |
| Bartholdson John A. filed to buy 6,939,357 shares at $8.5. August 20 '24 |
| Bartholdson John A. filed to buy 6,913,857 shares at $8.5. August 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$89.32 0% | 60 |
 |
Edwards LifesciencesEW |
$74.03 0% | 41 |
 |
Intuitive SurgicalISRG |
$521.96 0% | 65 |
 |
MedtronicMDT |
$79.88 0% | 41 |
 |
StrykerSYK |
$360.05 0% | 52 |
Read more about Bioventus (BVS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bioventus?
The Market Cap of Bioventus is $686M.
What is the current stock price of Bioventus?
Currently, the price of one share of Bioventus stock is $10.50.
How can I analyze the BVS stock price chart for investment decisions?
The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.
Does BVS offer dividends to its shareholders?
As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bioventus?
Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.